Updated: Mar 15
Guermazi is the first radiologist to receive this honor.
Dr. Guermazi, who also is the founder and director of the Quantitative Imaging Center at BUSM and BMC, is a French board-certified radiologist. His research interests include musculoskeletal diseases and in particular identifying structural risk factors for developing and worsening osteoarthritis. The award was presented during the Opening Ceremony at the OARSI World Congress in Liverpool, England, on Friday, April 27.
The OARSI Clinical Research Award recognizes excellence in clinical research related to osteoarthritis in areas such as epidemiology and health services research, clinical outcomes, translational research and therapeutics, encompassing all phases of research having clinical implications.
Dr. Guermazi has been involved in developing several original and widely accepted radiological methods to assess osteoarthritis disease risk and progression. He has served as an MRI reader for several large U.S. research projects, including the Health Aging and Body Composition (Health ABC) study, the Boston Osteoarthritis Knee Study (BOKS), the Multi-center Osteoarthritis STudy (MOST), the Framingham study, Osteoarthritis Initiative (OAI) and other large National Institutes of Health-funded studies, in addition to several pharmaceutical-sponsored clinical trials.
In 2013, Dr. Guermazi was appointed Deputy Editor of the musculoskeletal imaging section for the RADIOLOGY journal (RSNA). He also is the Expert Radiologist to the International Olympic Committee (IOC) since 2016 and has authored or co-authored more than 450 peer-reviewed papers and made numerous scientific presentations at National and International osteoarthritis, rheumatology and radiology meetings.
OARSI is the premier international organization for scientists and health care professionals focused on the prevention and treatment of osteoarthritis through the promotion and presentation of research, education and the worldwide dissemination of new knowledge.